Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Philippa C, Matthews"'
Autor:
Tingyan Wang, David A. Smith, Cori Campbell, Jolynne Mokaya, Oliver Freeman, Hizni Salih, Anna L. McNaughton, Sarah Cripps, Kinga A. Várnai, Theresa Noble, Kerrie Woods, Jane Collier, Katie Jeffery, Jim Davies, Eleanor Barnes, Philippa C. Matthews
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-14 (2021)
Abstract Background Current clinical guidelines recommend treating chronic hepatitis B virus (HBV) infection in a minority of cases, but there are relatively scarce data on evolution or progression of liver inflammation and fibrosis in cases of chron
Externí odkaz:
https://doaj.org/article/d84c383aa57b426b92d6b24788bacfce
Autor:
David W. Eyre, Sheila F. Lumley, Denise O’Donnell, Nicole E. Stoesser, Philippa C. Matthews, Alison Howarth, Stephanie B. Hatch, Brian D. Marsden, Stuart Cox, Tim James, Richard J. Cornall, David I. Stuart, Gavin Screaton, Daniel Ebner, Derrick W. Crook, Christopher P. Conlon, Katie Jeffery, Timothy M. Walker, Timothy E. A. Peto
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Thresholds for SARS-CoV-2 antibody assays have typically been determined using samples from symptomatic, often hospitalised, patients. In this setting the sensitivity and specificity of the best performing assays can both exceed 9
Externí odkaz:
https://doaj.org/article/b1f76dd17bd74f678b1aec65c50dda88
Autor:
Emily Adland, Gerald Jesuthasan, Louise Downs, Victoria Wharton, Gemma Wilde, Anna L. McNaughton, Jane Collier, Eleanor Barnes, Paul Klenerman, Monique Andersson, Katie Jeffery, Philippa C. Matthews
Publikováno v:
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background As direct acting antiviral (DAA) therapy is progressively rolled out for patients with hepatitis C virus (HCV) infection, careful scrutiny of HCV epidemiology, diagnostic testing, and access to care is crucial to underpin improvem
Externí odkaz:
https://doaj.org/article/48412c574cd548eb9f1b4f5321dd2505
Autor:
Jane Collier, Eleanor Barnes, Theresa Noble, Katie Jeffery, David Smith, Hizni Salih, Jim Davies, Anna L McNaughton, Sarah Cripps, Kerrie Woods, Kinga A Várnai, Tingyan Wang, Cori Campbell, Oliver Freeman, Jolynne Mokaya, Philippa C Matthews
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-14 (2021)
Wang, T, Smith, D A, Campbell, C, Mokaya, J, Freeman, O, Salih, H, McNaughton, A, Cripps, S, Várnai, K A, Noble, T, Woods, K, Collier, J, Jeffery, K, Davies, J, Barnes, E & Matthews, P C 2021, ' Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated : a retrospective longitudinal UK cohort study ', BMC Infectious Diseases, vol. 21, 610 . https://doi.org/10.1186/s12879-021-06226-0
BMC Infectious Diseases
Wang, T, Smith, D A, Campbell, C, Mokaya, J, Freeman, O, Salih, H, McNaughton, A, Cripps, S, Várnai, K A, Noble, T, Woods, K, Collier, J, Jeffery, K, Davies, J, Barnes, E & Matthews, P C 2021, ' Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated : a retrospective longitudinal UK cohort study ', BMC Infectious Diseases, vol. 21, 610 . https://doi.org/10.1186/s12879-021-06226-0
BMC Infectious Diseases
BackgroundCurrent clinical guidelines recommend treating chronic hepatitis B virus (HBV) infection in a minority of cases, but there are relatively scarce data on evolution or progression of liver inflammation and fibrosis in cases of chronic HBV (CH
Autor:
Timothy M Walker, Daniel Ebner, Philippa C Matthews, David I. Stuart, Stephanie B Hatch, Denise O'Donnell, Brian D. Marsden, Katie Jeffery, Alison Howarth, Gavin R. Screaton, D W Crook, Nicole Stoesser, Tim James, Peto Tea., David W Eyre, Christopher P. Conlon, Sheila F Lumley, Stuart Cox, Richard J. Cornall
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Thresholds for SARS-CoV-2 antibody assays have typically been determined using samples from symptomatic, often hospitalised, patients. In this setting the sensitivity and specificity of the best performing assays can both exceed 98%. Howev
Autor:
Philippa C Matthews, Nicola Jones, Lucinda K. Barrett, Stephanie Warren, Mel Snelling, Nicole Stoesser, Matthew Scarborough
Publikováno v:
BMC Infectious Diseases
Background Fosfomycin is increasingly called upon for the treatment of multi drug-resistant (MDR) organisms causing urinary tract infection (UTI). We reviewed oral fosfomycin use for UTI treatment in a large UK hospital. The primary goal was to audit
Autor:
Anna Maria Geretti, Philip J. R. Goulder, Paul Klenerman, Thumbi Ndung'u, Apostolos Beloukas, Amna Malik, Philippa C Matthews
Publikováno v:
BMC Infectious Diseases
Anti-Retroviral Therapy (ART) has dramatically reduced morbidity and mortality associated with HIV/AIDS. However, this has left a niche for the emergence of liver disease in HIV-positive individuals co-infected with HBV. Despite the geographical over
Autor:
Philippa C Matthews, Philip J. R. Goulder, Emily Adland, Pieter Jooste, Paul Klenerman, Amna Malik, Peter Simmonds, Colin P. Sharp
Publikováno v:
Matthews, P, Sharp, C, Malik, A, Adland, E, Jooste, P, Goulder, P, Simmonds, P & Klenerman, P 2014, ' Paediatric PARV4 infection in South Africa: relationship to age, maternal PARV4 status, and HIV infection ' pp. P92 . DOI: 10.1186/1471-2334-14-S2-P92
BMC Infectious Diseases
BMC Infectious Diseases
First identified in 2005, PARV4 is best characterized in Western cohorts where it is strongly associated with other blood borne viruses and occurs only in individuals with risk factors for parenteral infection (in particular, injecting drug users). H